CS Paper Radar

Answering clinicians' questions over trial evidence tables with verifiable, feedback-driven language models

Manan Roy Choudhury, Suparno Roy Chowdhury, Swastik Sahoo, Muhammad Ali Khan, Kaneez Zahra Rubab Khakwani, Mohamad Bassam Sonbol, Irbaz Bin Riaz, Vivek Gupta

cs.AI ·submitted 2026-10-01 23:12 UTC · v1
published

Abstract

Systematic reviews condense clinical trials into evidence tables, yet clinicians can interrogate these tables only through database queries, and many questions concern attributes that the table does not record, such as a drug's target class or a harmonised endpoint. Here we introduce FD-SCoPE, a language-model framework that answers both kinds of question, exposes the query, the selected trials and the derivation rule behind every answer, and learns from expert corrections. On an oncology evidence table of 159 immune checkpoint inhibitor trial records, FD-SCoPE completed all 140 clinician-style tasks (alternatives, 90.7-97.9%). For questions needing derived attributes it retrieved 99.3% of relevant trial records at a positive predictive value of 89.8% and outperformed four alternative approaches (derived-value F1 77.7% versus 64.8-73.4%). Corrections on 299 questions, simulated from reference answers, raised F1 on 1,201 unseen questions from 77.9% to 84.9%. Language models coupled with executable queries, verified programs and expert feedback can give clinicians auditable access to trial evidence.

Closest papers

Nearest neighbours by meaning across the whole index.

Clinician use of language models diverges from how the models are evaluated

cs.CL ·2026-10-08 ·Krithik Vishwanath, Haitong Lin, Anton Alyakin, Jin Vivian Lee, D. Brock Hewitt +17 more
benchmark similarity 0.71
Abstract

Large language model (LLM) assistants are being deployed to clinicians across health systems, and judgments about their readiness rest largely on benchmark scores, most of them derived from examination questions or curated cases. A benchmark predicts performance in deployment only to the extent that its items resemble real use, yet whether benchmarks reflect the work these systems receive has rarely been measured. Here we analyze 127,833 queries sent by 6,342 physicians, advanced practice providers and nurses in 35 specialties to an institutional assistant during an eight-month roll-out. We characterize each query with RCQ-Map, a clinician-validated framework grounded in taxonomies of clinical questions and of LLM evaluation, which records its task, intent, answerability, missing information and potential harm. Documentation and administration (36.2%) and knowledge retrieval (28.9%) made up nearly two-thirds of use, and diagnosis 3.7%; more than a third of queries could not be answered well as posed. Applying RCQ-Map to 58 public benchmarks drawn from major evaluation suites and frontier model reports, which we assemble into the Clinical AI Benchmark Atlas, showed that the median benchmark contained no documentation requests and shared 31% of the task mix of real use, less than an even spread across task categories would. Benchmarks in suites designed to resemble clinical practice were individually no closer to real use than those used in frontier model reports. Benchmark scores therefore say little about how clinical AI performs on most of the work it is actually given, and evaluation should be matched to real clinical use.

0.08

TrialJev: Open-Weight Single Pass Eligibility Scoring for Patient Trial Screening

cs.LG ·2026-11-06 ·Omar Ibrahim, Grant Hamblin, Benjamin Haibe-Kains
code/data similarity 0.69
Abstract · 38 pages. Code: https://github.com/oibrahi1/TrialJev. Models: https://huggingface.co/omareng/TrialJev

Clinical trial screening requires assessing large numbers of patient-trial pairs to prioritize candidates for detailed eligibility review, often under restrictions on sharing patient records. We introduce TrialJev, an open-weight eligibility scorer that uses LoRA-adapted Qwen models and a pointer head to score natural-language answer options in a single forward pass, without autoregressive decoding. Trained on TREC Clinical Trials 2021 and evaluated on 6,975 eligible-or-excluded pairs from 50 unseen TREC 2022 synthetic patients, TrialJev achieves 80.97% (Qwen3.5-27B) and 81.84% (Qwen3.8-27B) accuracy, compared with 79.87% and 79.93% for LLMs fine-tuned on the same data to generate verdicts. In matched batch-1 measurements, verdict generation takes 2.45-2.70 times as long as the one-pass inference of TrialJev at 9B-27B. Under a common development-fitted decision correction, the two 27B TrialJev models reach 80.99% and 81.88% accuracy, compared with 81.28% for the proprietary hosted Jev API; paired confidence intervals include zero. TrialJev runs locally on a single GPU, requiring approximately 178 ms per pair at 27B, without transmitting patient text to an external model API. An A/B-logit ablation shows that avoiding decoding, rather than the pointer head alone, accounts for the measured efficiency advantage. TrialJev is intended for first-pass prioritization of candidate trials, complementing rather than replacing explanatory models and clinical review. Evaluation is limited to synthetic patients and implementation-specific timing, and clinical use has not been validated. Adapters, pointer heads, and model cards are released on Hugging Face.

0.22

ROUNDS: Source-Framed Diagnostic Revision after Multi-Turn Clinical Evidence

cs.CL cs.AI ·2026-11-14 ·Jinrui Fang, Runhan Chen, Yining Wu, Jiawei Xu, Xu Yang +4 more
top venuebenchmark similarity 0.68
Abstract · Accepted at Machine Learning for Health (ML4H) 2026, Proceedings Track; to appear in Proceedings of Machine Learning Research (PMLR). 17 pag…

Large language models (LLMs) achieve high scores on medical benchmarks, but does this performance translate into reliable diagnosis as a conversation unfolds? In diagnostic conversations, users can provide clinical findings across multiple turns, ask for a diagnosis without supplying answer options, and introduce opinions from others. Models must therefore form diagnoses from the available evidence and decide how to respond to subsequent advice. We introduce ROUNDS, a framework that evaluates these abilities after a fixed sequence of clinical evidence delivered over multiple turns. ROUNDS compares diagnosis with and without answer options, presents the same incorrect diagnosis under clinician and lay framing, and varies support for competing diagnoses in written five-clinician panels. Across seven models and 1,035 cases from five datasets, average accuracy was 76.9% with answer options and 57.0% without them. Clinician-framed misleading advice produced lower final accuracy than lay-framed advice in every model, with differences of 4.6 to 38.2 percentage points. Initially correct diagnoses more often became incorrect answers than abstentions, and many adopted the suggested disease. Conversely, accuracy increased as more panel members supported the correct diagnosis, including when the majority opinion remained unchanged. These findings reveal a gap between medical benchmark performance and reliable diagnosis in conversation: models respond to external opinions, but remain vulnerable to abandoning correct diagnoses without new clinical evidence.

0.34

PCQC: Privileged Counterfactual Question Credit for Multi-Turn Medical Dialogue

cs.LG ·2026-09-23 ·Chenxuan Li, Jiayi Wan, Xinrong Chen, Zhongyu Zhao, Xuecheng Shang +1 more
similarity 0.67
Abstract · 19 pages, 4 figures, 13 tables

Large language models (LLMs) have made substantial progress on medical question-answering, yet effective medical dialogue also requires learning to ask questions that uncover relevant patient information. To train such dialogue policies, a common pipeline combines supervised fine-tuning with reinforcement learning (RL) based on final diagnostic correctness. However, this outcome-based supervision does not directly distinguish the contributions of individual questions and provides no question-level feedback for unexecuted alternatives. To address this gap, we introduce PCQC (Privileged Counterfactual Question Credit), which uses privileged patient information during training to learn from questions never asked. During training, PCQC makes alternative questions directly comparable at the same dialogue state by using privileged patient facts to construct their answers. A frozen diagnostic scorer evaluates the diagnostic utility of each resulting question-answer pair by how strongly it supports the correct diagnosis. PCQC turns these comparisons into relative question credit that teaches the policy which questions to favor, directly supervising both executed and unexecuted questions alongside outcome-based RL without requiring complete rollouts for the unexecuted alternatives. Extensive experiments across four medical benchmarks demonstrate that PCQC achieves 63.10% mean diagnostic accuracy, outperforming GRPO and ATPO by 4.38 and 4.21 percentage points, respectively. These gains are achieved with 33.1% fewer inquiry turns than GRPO.

0.16

SentryLine: Evidence-Grounded Question Answering over Evolving Documents in Oncology Care

cs.CL ·2026-09-08 ·Tampu Ravi Kumar, Gaurav Najpande, Muhammad Ali Khan, Kaneez Zahra Rubab Khakwani, Karan Kathuria +5 more
top venuebenchmark similarity 0.67
Abstract

Oncology care operates at constant pressure of absorbing rapidly evolving evidence base in biomedicine. The American Society of Clinical Oncology (ASCO) addresses this through living guidelines, but the format introduces a new burden: any recommendation can change at any point, across multiple versioned documents. We present SENTRYLINE, a living guideline-aware clinical question answering system. SENTRYLINE retrieves guideline passages through a vectorless hierarchical RAG pipeline and returns a role-specific answer with inline citations, factual and temporal verification reports, and drift detection notes that surface when a guideline has been updated. We construct ASCOBENCH, a benchmark of 405 three-turn conversations across four question categories with gold answers from expert annotators(clinicians), and use test set to evaluate SENTRYLINE against five baselines under an LLM-as-judge framework. Experiments across three generation backbones show consistent improvements over four retrieval baselines and ASCO's guideline assistant, with particularly strong gains on Reasoning and Role-Specific questions where multi-hop synthesis and register adaptation are required

0.69

Decisions by Discrimination: Differential Evidence for Medical Reasoning

cs.AI ·2026-11-09 ·Yunpeng Xiao, Yuzhang Xie, Junhao Huang, Carl Yang, Xiao Hu +1 more
published similarity 0.66
Abstract · Accepted by AACL 2026 (main)

Large language models (LLMs) are increasingly studied for clinical decision support, and medical question answering provides a testbed for evaluating this capability. In particular, medical multiple-choice questions (MCQs) reflect a core challenge in clinical decision-making: plausible options often share overlapping evidence, while only a few decisive factors distinguish the correct option from incorrect ones. However, existing retrieval-based and reasoning-oriented methods mainly focus on supplying broadly relevant knowledge or eliciting reasoning paths, rather than identifying the compact differential evidence that separates confusing alternatives. In this work, we present a retrieval-grounded differential evidence framework for medical MCQs. Our method extracts option-specific pieces of differential evidence and organizes them into concise evidence prompts for answer selection. This design better aligns external knowledge with differential reasoning while reducing irrelevant context. Experiments show consistent accuracy gains across multiple datasets and target LLMs. Ablation studies further show that our framework outperforms both directly using retrieved evidence chunks and closed-source LLM-generated general hints, and that its improvements are not solely explained by answer-proximal guidance, but are consistent with differential evidence serving as a compact aid for reasoning over competing alternatives. Our findings also offer insights for medical reasoning and other decision-making settings with multiple possible choices.

0.21

CARF: Context-Aware Reasoning Supervision for Scientific Evidence Screening

cs.CL ·2026-10-27 ·Nishtha Agarwal, Adam Visokay, Astha Wahi, Kwabena Owusu Aninkora, Amy Gu +2 more
similarity 0.66
Abstract

Systematic reviews synthesize biomedical evidence to inform clinical and public-health decision-making, but require domain experts to manually screen thousands of studies against detailed eligibility criteria. We investigate whether language models can assist with this bottleneck by learning from expert feedback on title and abstract screening decisions and model-generated reasoning. We introduce the Context-Aware Reasoning Framework (CARF), a human-in-the-loop framework that uses expert feedback on model-generated reasoning to adapt language models to context-dependent screening tasks. We evaluate CARF on systematic reviews of verbal autopsy and cause-of-death ascertainment methods used in global public health mortality surveillance. CARF shows competitive screening performance compared to evaluated models while retaining high sensitivity, and is more inclined to retain ambiguous, context-dependent studies for human review. Together, these findings suggest that expert-corrected reasoning is a promising supervision signal for context-dependent scientific screening, while retaining a role for human oversight.

0.18

Scaling large language model-assisted line-of-therapy adjudication with human-in-the-loop evidence-calibrated selection

cs.LG q-bio.QMstat.AP ·2026-11-15 ·Olatunji Oni, Sanhita Sengupta, Marc De Benedetti, Nathanial Eddy
similarity 0.66
Abstract · 12 pages, 4 figures

Large language models (LLMs) have enabled the ability to scale clinical adjudication tasks traditionally dependent on exhaustive manual review. Line-of-therapy (LoT) adjudication, a major bottleneck in oncology cohort construction, is a prime example. Line boundaries must be inferred from longitudinal treatment histories according to nuanced, study-specific definitions, at every regimen transition for every patient. LLMs can apply this adjudication at scale, but their reliability varies across patients. Treatment histories differ in complexity, and ambiguous or atypical patterns depend on expert clinical judgment. Reliable automation thus requires verified support for model assignments and the ability to identify cases that warrant manual review. Here, we present evidence-calibrated selection (ECS), a human-in-the-loop framework for scaling LLM-assisted LoT adjudication. ECS derives confidence from observed clinician adjudications, prioritizes patients with the least-supported assignments for follow-up review, and returns completed adjudications to the model as precedent. As the evidence base grows, ECS continuously calibrates confidence to estimate residual error, thus enabling more efficient use of clinician time. In simulations on 136 clinician adjudicated patients with multiple myeloma, ECS achieved a residual error of 5% after review of 44.6% of patients, compared to 62.2% when review was directed by LLM self-reported confidence and 81.9% under random sampling. These results support a scalable approach to study-specific LoT adjudication, using clinician evidence to inform automated predictions, minimize error, and reduce review burden.

0.26